SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-709742
Filing Date
2016-09-14
Accepted
2016-09-14 16:50:05
Documents
10
Period of Report
2016-09-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d261314d8k.htm 8-K 15723
2 EX-99.1 d261314dex991.htm EX-99.1 59863
3 GRAPHIC g261314g02t18.jpg GRAPHIC 69605
4 GRAPHIC g261314g20j66.jpg GRAPHIC 116323
5 GRAPHIC g261314g32q38.jpg GRAPHIC 146437
6 GRAPHIC g261314g43p26.jpg GRAPHIC 95259
7 GRAPHIC g261314g64z25.jpg GRAPHIC 107829
8 GRAPHIC g261314g83x05.jpg GRAPHIC 70547
9 GRAPHIC g261314g97k56.jpg GRAPHIC 52719
10 GRAPHIC g261314g98a48.jpg GRAPHIC 141495
  Complete submission text file 0001193125-16-709742.txt   1179867
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36561 | Film No.: 161885503
SIC: 2834 Pharmaceutical Preparations